The engagement between physicians and their patients is an important part of a successful health care outcome.
To study how this can happen more effectively, the National Health Council and Genetic Alliance recently teamed up and invited a group of key officials to examine the issue and later released the group's findings in a white paper called "Dialogue/Advancing Meaningful Patient Engagement in Research, Development and Review of Drugs."
The report focused on:
- The uncertainty about how patient-provided data will impact product approval by the Food and Drug Administration (FDA)
- The cultural divide over the use of patient information
- The gap in knowledge and information about patient-engagement methods, best practices and successes
Additionally, the report addressed possible action steps related to these issues, as well as the need to create regulatory guardrails and enhance FDA division alignment on the use
of tools for evaluating patient information.
The white paper was compiled by Avalere Health. The forum from which information was gleaned took place in March at the FDA's White Oak Campus in Maryland.
The paper can be downloaded at www.nationalhealthcouncil.org or www.geneticalliance.org.
Health Council, Genetic Alliance release report on doctor-patient engagement
Organizations in this Story
Want to get notified whenever we write about National Health Council ?
Next time we write about National Health Council, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.Sign-up for Alerts